Skip to main content
. 2015 Aug 4;17(2):466–473. doi: 10.1208/s12249-015-0370-5

Fig. 7.

Fig. 7

Plasma concentration–time profiles of erlotinib after oral administration of powder and solid SEDDS formulations in rats. Each value represents the mean ± S.D. (n = 4). Erlotinib powder (black square), solid SEDDS prepared with dextran 40 (white circle), and solid SEDDS prepared with Aerosil® 200 (black circle)